Impaired Wound Healing with Imatinib Mesylate Therapy
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved..
ABSTRACT: Medication-induced ulcers are generally rare. Although the tyrosine kinase inhibitor imatinib mesylate is frequently prescribed, the occurrence of ulcers related to the medication has not been previously described. Herein, the authors report a case of a patient with impaired wound healing that was attributed to imatinib mesylate treatment. Providers should maintain suspicion for medication-induced ulcers, particularly if treatment for the presumed underlying cause of an ulcer fails.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Advances in skin & wound care - 34(2021), 2 vom: 01. Feb., Seite 109-111 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ronicke, Moritz [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
8A1O1M485B |
|---|
| Anmerkungen: |
Date Completed 19.10.2021 Date Revised 19.10.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1097/01.ASW.0000725176.48771.0f |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM32007174X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32007174X | ||
| 003 | DE-627 | ||
| 005 | 20231225172808.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/01.ASW.0000725176.48771.0f |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1066.xml |
| 035 | |a (DE-627)NLM32007174X | ||
| 035 | |a (NLM)33443914 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ronicke, Moritz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impaired Wound Healing with Imatinib Mesylate Therapy |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.10.2021 | ||
| 500 | |a Date Revised 19.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. | ||
| 520 | |a ABSTRACT: Medication-induced ulcers are generally rare. Although the tyrosine kinase inhibitor imatinib mesylate is frequently prescribed, the occurrence of ulcers related to the medication has not been previously described. Herein, the authors report a case of a patient with impaired wound healing that was attributed to imatinib mesylate treatment. Providers should maintain suspicion for medication-induced ulcers, particularly if treatment for the presumed underlying cause of an ulcer fails | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Imatinib Mesylate |2 NLM | |
| 650 | 7 | |a 8A1O1M485B |2 NLM | |
| 700 | 1 | |a Erfurt-Berge, Cornelia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Advances in skin & wound care |d 2000 |g 34(2021), 2 vom: 01. Feb., Seite 109-111 |w (DE-627)NLM109780892 |x 1538-8654 |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2021 |g number:2 |g day:01 |g month:02 |g pages:109-111 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/01.ASW.0000725176.48771.0f |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2021 |e 2 |b 01 |c 02 |h 109-111 | ||